Cortexyme () P/BV US GAAP (year values) |
||||||||
2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | |||
P/BV | ? | 0.00 | 0.00 | 9.27 | 4.71 | 3.17 | 687.7 | |
Changes by years, y/y, % | -49% | -33% |
Cortexyme. P/BV
Cortexyme. P/BV, changes, %
Cortexyme () P/BV US GAAP (quarter values) |
||||||||
2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
P/BV | ? | 11.0 | 20.6 | 3.17 | 1.75 | 687.7 | 687.7 | |
Changes by years, y/y, % | +66% | +162% | -33% | -74% | +6 131% | |||
Changes by quarters, q/q, % | +62% | +86% | -85% | -45% | +39 120% |